Mark H Pollack Selected Research

Social Phobia

1/2020	Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical Trial.
1/2019	Effect of d-cycloserine on fear extinction training in adults with social anxiety disorder.
5/2014	Influence of RGS2 on sertraline treatment for social anxiety disorder.
1/2014	A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder.
12/2013	D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables.
11/2013	Sleep quality predicts treatment outcome in CBT for social anxiety disorder.
10/2013	D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions.
10/2013	Smiles may go unseen in generalized social anxiety disorder: evidence from binocular rivalry for reduced visual consciousness of positive facial expressions.
7/2013	D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder.
11/2012	Plasma oxytocin immunoreactive products and response to trust in patients with social anxiety disorder.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark H Pollack Research Topics

Disease

35	Anxiety Disorders (Anxiety Disorder) 12/2019 - 01/2002
26	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 02/2024 - 08/2003
25	Panic Disorder (Panic Attack) 01/2016 - 05/2002
23	Social Phobia 01/2020 - 09/2002
4	Sleep Initiation and Maintenance Disorders (Insomnia) 03/2020 - 01/2009
4	Substance-Related Disorders (Drug Abuse) 01/2013 - 10/2004
4	Agoraphobia 01/2009 - 07/2002
2	Wounds and Injuries (Trauma) 08/2020 - 01/2007
2	Phobic Disorders (Phobia) 06/2013 - 03/2006
2	Major Depressive Disorder (Major Depressive Disorders) 03/2012 - 10/2010
2	Treatment-Resistant Depressive Disorder 10/2010 - 01/2005
2	Bipolar Disorder (Manic Depressive Psychosis) 04/2009 - 10/2004
2	Dizziness (Lightheadedness) 01/2009 - 07/2005
2	Weight Gain 02/2007 - 02/2006
1	Pain (Aches) 01/2019
1	Acidosis 12/2014
1	Asphyxia (Suffocation) 12/2014
1	Hypersensitivity (Allergy) 12/2014
1	Psychological Trauma 01/2012
1	Mood Disorders (Mood Disorder) 04/2009
1	Weight Loss (Weight Reduction) 08/2008
1	Nausea 08/2008
1	Autistic Disorder (Autism) 01/2008
1	Schizophrenia (Dementia Praecox) 01/2008
1	Tuberculosis (Tuberculoses) 11/2006
1	Medically Unexplained Symptoms 09/2005
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 10/2004
1	Heroin Dependence (Heroin Abuse) 09/2004
1	Opioid-Related Disorders (Opiate Addiction) 07/2004
1	Stroke (Strokes) 07/2004
1	Ischemia 07/2004
1	Psychomotor Disorders 08/2003

Drug/Important Bio-Agent (IBA)

16	Cycloserine (Seromycin)FDA Link 01/2020 - 03/2006
10	BenzodiazepinesIBA 03/2020 - 06/2003
7	Inosine Triphosphate (ITP)IBA 01/2022 - 01/2020
7	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2022 - 01/2018
7	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 05/2014 - 01/2003
6	Paroxetine (Paxil)FDA LinkGeneric 05/2008 - 01/2003
5	Antidepressive Agents (Antidepressants)IBA 01/2017 - 01/2003
5	Duloxetine Hydrochloride (Cymbalta)FDA Link 07/2010 - 08/2008
5	gamma-Aminobutyric Acid (GABA)IBA 04/2009 - 11/2005
5	Anti-Anxiety Agents (Anxiolytics)IBA 04/2008 - 10/2004
4	Sertraline (Zoloft)FDA LinkGeneric 05/2014 - 07/2002
4	Levetiracetam (Keppra)FDA LinkGeneric 05/2010 - 09/2004
4	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 01/2009 - 06/2003
4	Tiagabine (Gabitril)FDA Link 01/2009 - 11/2005
4	Antipsychotic Agents (Antipsychotics)IBA 01/2009 - 01/2004
3	Clonazepam (Rivotril)FDA LinkGeneric 01/2014 - 09/2003
3	Methadone (Dolophine)FDA LinkGeneric 01/2013 - 09/2004
3	Aripiprazole (Abilify)FDA Link 03/2012 - 01/2005
3	Anticonvulsants (Antiepileptic Drugs)IBA 05/2010 - 01/2004
3	Serotonin (5 Hydroxytryptamine)IBA 01/2009 - 02/2006
3	Fluoxetine (Prozac)FDA LinkGeneric 02/2006 - 07/2005
2	Eszopiclone (Lunesta)FDA Link 03/2020 - 07/2011
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2013 - 03/2006
2	Oxytocin (Pitocin)FDA LinkGeneric 11/2012 - 01/2008
2	Glutamine (L-Glutamine)FDA Link 04/2009 - 04/2008
2	Glutamic Acid (Glutamate)FDA Link 04/2009 - 04/2008
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2009 - 01/2007
2	N 30IBA 12/2006 - 01/2005
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2024
1	lipopolysaccharide-binding proteinIBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Succinic Acid (Succinate)IBA 01/2022
1	HMGB1 Protein (HMG1)IBA 01/2022
1	Aligeron (AS 2)IBA 11/2021
1	Aminobutyrates (Aminobutyric Acid)IBA 03/2020
1	Indicators and Reagents (Reagents)IBA 10/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Nootropic Agents (Nootropics)IBA 07/2015
1	Carbon DioxideIBA 12/2014
1	Acid Sensing Ion ChannelsIBA 12/2014
1	Propranolol (Inderal)FDA LinkGeneric 01/2012
1	Hypnotics and Sedatives (Sedatives)IBA 07/2011
1	Heroin (Diamorphine)IBA 08/2010
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 01/2009
1	Quetiapine Fumarate (Seroquel)FDA Link 05/2008
1	NeuropeptidesIBA 01/2008
1	EnzymesIBA 01/2008
1	ImmunosorbentsIBA 01/2008
1	Biological FactorsIBA 01/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2006
1	Risperidone (Risperdal Consta)FDA LinkGeneric 03/2006
1	Olanzapine (Zyprexa)FDA Link 02/2006
1	A-factor (Streptomyces)IBA 01/2006
1	GABA Uptake InhibitorsIBA 11/2005
1	Alprazolam (Xanax)FDA LinkGeneric 09/2005
1	Pregabalin (Lyrica)FDA Link 09/2005
1	Cocaine (Cocaine HCl)IBA 07/2004
1	Estrogens (Estrogen)FDA Link 07/2004
1	Opiate AlkaloidsIBA 07/2004
1	Valproic Acid (Depakote)FDA LinkGeneric 05/2003
1	Bupropion (Wellbutrin)FDA LinkGeneric 01/2003

Therapy/Procedure

24	Drug Therapy (Chemotherapy) 03/2020 - 05/2002
16	Therapeutics 01/2022 - 01/2002
3	Aftercare (After-Treatment) 01/2022 - 06/2003
3	Meditation 01/2018 - 08/2013
1	Telescopes 10/2013
1	Treatment Delay 01/2009
1	Duration of Therapy 01/2004